Total Payments
$2.2M
2024 Payments
$255,270
Companies
47
Transactions
2,348
Medicare Patients
5,797
Medicare Billing
$589,608
Payment Breakdown by Category
Other$1.1M (50.6%)
Consulting$890,717 (40.4%)
Travel$86,161 (3.9%)
Food & Beverage$59,935 (2.7%)
Research$50,000 (2.3%)
Education$746.80 (0.0%)
Gifts$38.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $890,717 | 472 | 40.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $862,460 | 371 | 39.1% |
| Travel and Lodging | $86,161 | 313 | 3.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $83,263 | 28 | 3.8% |
| Honoraria | $65,250 | 31 | 3.0% |
| Food and Beverage | $59,935 | 1,105 | 2.7% |
| Acquisitions | $55,113 | 1 | 2.5% |
| Unspecified | $50,000 | 2 | 2.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $41,850 | 16 | 1.9% |
| Entertainment | $6,000 | 4 | 0.3% |
| Current or prospective ownership or investment interest | $2,190 | 1 | 0.1% |
| Education | $746.80 | 2 | 0.0% |
| Gift | $38.80 | 2 | 0.0% |
Payments by Type
General
$2.2M
2,346 transactions
Research
$50,000
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $600,772 | 639 | $0 (2022) |
| Alcon Vision LLC | $278,427 | 367 | $0 (2024) |
| ABBVIE INC. | $176,638 | 186 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $140,573 | 127 | $0 (2021) |
| Sight Sciences, Inc. | $132,519 | 141 | $0 (2024) |
| Reichert, Inc. | $127,438 | 71 | $0 (2024) |
| Alcon Research LLC | $102,260 | 27 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $98,271 | 101 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $82,492 | 73 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $67,374 | 59 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255,270 | 350 | Alcon Vision LLC ($77,761) |
| 2023 | $322,385 | 341 | Alcon Vision LLC ($82,876) |
| 2022 | $321,223 | 305 | Alcon Vision LLC ($97,462) |
| 2021 | $331,100 | 320 | Allergan, Inc. ($134,038) |
| 2020 | $295,332 | 241 | Allergan, Inc. ($161,087) |
| 2019 | $278,046 | 310 | Allergan Inc. ($82,500) |
| 2018 | $300,774 | 324 | Allergan Inc. ($108,396) |
| 2017 | $99,596 | 157 | Allergan Inc. ($45,421) |
All Payment Transactions
2,348 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | DURYSTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,625.00 | General |
| Category: EYE CARE | ||||||
| 12/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/20/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: EYE CARE | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | Alcon Research LLC | HYDRUS Microstent (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 12/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $124.62 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | ABBVIE INC. | DURYSTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,725.00 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $215.60 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Dry eyes | ||||||
| 12/03/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $291.17 | General |
| Category: Dry eyes | ||||||
| 12/03/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $171.81 | General |
| Category: Dry eyes | ||||||
| 12/03/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Travel and Lodging | Cash or cash equivalent | $46.70 | General |
| Category: Dry eyes | ||||||
| 11/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: EYE CARE | ||||||
| 11/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Travel and Lodging | Cash or cash equivalent | $359.48 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Travel and Lodging | Cash or cash equivalent | $121.49 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Travel and Lodging | Cash or cash equivalent | $87.73 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Travel and Lodging | In-kind items and services | $526.83 | General |
| Category: EYE CARE | ||||||
| 11/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Travel and Lodging | In-kind items and services | $198.51 | General |
| Category: EYE CARE | ||||||
| 11/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $73.08 | General |
| Category: EYE CARE | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,062.50 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Dry eyes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| The Prevalence of Musculoskeletal Complaints in Ophthalmologists and the Impact of Heads Up Display | Alcon Research LLC | $50,000 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,264 | 1,545 | $497,317 | $123,943 |
| 2022 | 22 | 1,236 | 1,458 | $534,763 | $130,145 |
| 2021 | 25 | 1,897 | 2,297 | $906,292 | $209,932 |
| 2020 | 20 | 1,400 | 1,661 | $536,060 | $125,588 |
Total Patients
5,797
Total Services
6,961
Medicare Billing
$589,608
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 344 | $68,805 | $24,863 | 36.1% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2023 | 19 | 22 | $71,456 | $23,411 | 32.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 30 | 45 | $119,157 | $17,183 | 14.4% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 12 | 18 | $48,482 | $11,120 | 22.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 230 | 314 | $51,185 | $9,356 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 76 | $23,140 | $7,347 | 31.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 128 | 136 | $20,400 | $7,223 | 35.4% |
| 92250 | Photography of the retina | Office | 2023 | 88 | 90 | $12,950 | $2,897 | 22.4% |
| 92132 | Imaging of front third of eye | Office | 2023 | 110 | 123 | $24,600 | $2,851 | 11.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 32 | 33 | $5,065 | $2,703 | 53.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 24 | 24 | $6,000 | $2,621 | 43.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 27 | 29 | $6,560 | $2,573 | 39.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,025 | $2,048 | 50.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 49 | 51 | $9,403 | $1,988 | 21.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 40 | $6,445 | $1,954 | 30.3% |
| 92134 | Imaging of retina | Office | 2023 | 32 | 33 | $4,881 | $1,050 | 21.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 38 | 38 | $3,375 | $885.13 | 26.2% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 23 | 23 | $4,250 | $831.80 | 19.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 57 | 59 | $5,700 | $799.90 | 14.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 24 | 24 | $1,438 | $237.24 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 202 | 279 | $53,030 | $20,488 | 38.6% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2022 | 15 | 18 | $59,456 | $19,671 | 33.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 30 | 40 | $114,887 | $17,328 | 15.1% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 19 | 27 | $73,351 | $16,635 | 22.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 210 | 268 | $44,724 | $7,918 | 17.7% |
About Dr. Nathan Radcliffe, M.D
Dr. Nathan Radcliffe, M.D is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124229810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Radcliffe, M.D has received a total of $2.2M in payments from pharmaceutical and medical device companies, with $255,270 received in 2024. These payments were reported across 2,348 transactions from 47 companies. The most common payment nature is "Consulting Fee" ($890,717).
As a Medicare-enrolled provider, Radcliffe has provided services to 5,797 Medicare beneficiaries, totaling 6,961 services with total Medicare billing of $589,608. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location New York, NY
- Active Since 05/30/2007
- Last Updated 05/28/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1124229810
Products in Payments
- DURYSTA (Drug) $300,823
- HYDRUS Microstent (Device) $163,840
- LUMIGAN (Drug) $105,475
- VYZULTA (Drug) $100,215
- VUITY (Drug) $84,493
- XEN (Device) $76,638
- Rhopressa (Drug) $67,527
- Ahmed Glaucoma Valve (Device) $58,481
- CyPass (Device) $53,889
- rocklatan (Drug) $52,001
- OMNI(R) SURGICAL SYSTEM (US) (Device) $48,039
- OMNI SURGICAL SYSTEM (Device) $46,807
- MIEBO (Drug) $41,288
- TRAVATAN Z (Drug) $40,091
- Centurion (Device) $36,358
- Hydrus (Device) $36,066
- TYRVAYA (Drug) $33,488
- rhopressa (Drug) $32,844
- ALPHAGAN P (Drug) $28,060
- Rocklatan (Drug) $27,662
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New York
Dr. Tsontcho Ianchulev, M.d. Mph, M.D. MPH
Ophthalmology — Payments: $21.4M
Ophthalmology $21.4M
Dr. Joshua Young, M.d, M.D
Ophthalmology — Payments: $805,605
Ophthalmology $805,605
Dr. Raymond Fong, M.d, M.D
Ophthalmology — Payments: $581,936
Ophthalmology $581,936
Joseph Panarelli, M.d, M.D
Ophthalmology — Payments: $525,201
Ophthalmology $525,201
David Guyer
Ophthalmology — Payments: $491,407
Ophthalmology $491,407
Christopher Starr, Md, MD
Ophthalmology — Payments: $279,545
Ophthalmology $279,545